Agonist-induced increase in apparent beta-adrenergic receptor size.
about
Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist statesCoordinate regulation of G protein signaling via dynamic interactions of receptor and GAPCoupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptorAntagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.The superfamily of heptahelical receptors.Agonist-promoted coupling of the beta-adrenergic receptor with the guanine nucleotide regulatory protein of the adenylate cyclase system.Emergence of beta-adrenergic sensitivity in the developing chicken heart.Solubilization of human platelet alpha-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor--effector interactions.Structure of the turkey erythrocyte adenylate cyclase system.Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance.Evidence for internalization of the recognition site of beta-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol.Influence of the beta-adrenergic receptor concentration on functional coupling to the adenylate cyclase system.Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.The molecular structure of adrenergic and dopaminergic substances.Activation and attenuation of adenylate cyclase. The role of GTP-binding proteins as macromolecular messengers in receptor--cyclase coupling.Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity.Analysis of agonist-antagonist interactions at A1 adenosine receptors.Characteristics of the beta-adrenergic adenylate cyclase system of developing rabbit bone-marrow erythroblasts.Covalent labelling of the lutropin binding site. Evidence for a single Mr 90000 sialoglycopolypeptide.The Gordon Wilson lecture. Adrenergic receptors: regulation at the biochemical, physiological and clinical levels.Guanine nucleotide regulation of [3H]vasopressin binding to liver plasma membranes and solubilized receptors. Evidence for the involvement of a guanine nucleotide regulatory protein.Oxytocin receptors on cultured astroglial cells. Regulation by a guanine-nucleotide-binding protein and effect of Mg2+.Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C.Bradykinin recognizes different molecular forms of the B2 kinin receptor in the presence and absence of guanine nucleotides.Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.Angiotensin-induced changes in the apparent size of rat liver angiotensin receptors.Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors.
P2860
Q24602253-ED8F2751-89F3-4D8D-A701-F15C40762E11Q33361958-E86E7028-A7C5-4DDC-ACEE-287FC392E9F0Q34107273-E3CFA953-CF71-452A-BA04-D46D2AF469EFQ34306079-6B76F5F7-4A2E-41AE-8FDF-D934C8D8DB14Q34509487-6BA0809B-3481-490E-87AE-AB6E14F71BA8Q34708038-DDA2EC1D-5D96-44A7-874C-FF0CBF39880AQ35305962-D21294FD-0725-413E-A7F8-4929DAC64183Q35393040-9CA2F24D-2B02-4FDD-967C-149639463288Q35413638-D527C199-AE65-404C-8770-46144B729784Q36989823-4732973B-0264-44D1-A5CD-4F1BB4F1606DQ37334542-8FC63D8D-65DC-44AF-8DF7-EC055A02EEF6Q37560108-1738F38C-4A84-4D57-873D-F2646729DB5CQ38207936-2B70C4E2-290D-4F3C-A62C-BE6DFB4FCC1FQ39857353-E48829C2-9381-4F10-917F-BD88783915C2Q40126899-C596AA99-8157-4799-B18C-5052EAF2FD6AQ41079862-F950FED0-90D3-4B8B-9670-66CBD54A0523Q41194471-ADF746E9-D8D7-46BC-B675-A919B25E4AE9Q41827420-A896B820-21CC-4DB8-B0FA-F1E3E8954EA3Q41861296-4518510D-9043-4751-9494-7D986A9A19C4Q42114258-62FF4B6C-8494-4699-9599-1E863D1A1A44Q42137188-FFBFA245-24CB-496D-A6D8-ADDD34DF10A3Q42797578-0409DAC5-1923-41AD-91B1-A6283F8B2343Q42836501-6D3F805F-1C39-4F84-8A90-AD3D7886D050Q42861904-B2C9D447-06A4-4AC6-A6EE-8557EE6F4CC6Q44346836-EFA5C6FF-D052-48DA-87B5-1756AE6762E1Q47246418-8B88CF75-030F-4543-AA70-EE9B0AB1161DQ50337370-CF7DC59E-2A0F-4E41-B51C-CB778FFC2C01
P2860
Agonist-induced increase in apparent beta-adrenergic receptor size.
description
1978 nî lūn-bûn
@nan
1978 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Agonist-induced increase in apparent beta-adrenergic receptor size.
@ast
Agonist-induced increase in apparent beta-adrenergic receptor size.
@en
type
label
Agonist-induced increase in apparent beta-adrenergic receptor size.
@ast
Agonist-induced increase in apparent beta-adrenergic receptor size.
@en
prefLabel
Agonist-induced increase in apparent beta-adrenergic receptor size.
@ast
Agonist-induced increase in apparent beta-adrenergic receptor size.
@en
P2860
P356
P1476
Agonist-induced increase in apparent beta-adrenergic receptor size.
@en
P2093
Lefkowitz RJ
Limbird LE
P2860
P304
P356
10.1073/PNAS.75.1.228
P407
P577
1978-01-01T00:00:00Z